Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00335114

Enrollment

Registered

2006-06-08

Start date

2005-11-30

Completion date

2006-04-30

Last updated

2023-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contact Lens Wearers With Dry Eye Syndrome

Keywords

cyclosporine, dry eye syndrome, contact lens

Brief summary

Cyclosporine Ophthalmic Emulsion is currently used in the treatment of dry eye syndrome. Contact lens wearers frequently suffer from dry eye syndrome. The purpose of this study is to evaluate cyclosporine ophthalmic emulsion verses re-wetting drops in the relief of dry eye symptoms in contact lens wearers

Interventions

DRUGcyclosporine ophthalmic emulsion

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

Inclusion criteria

* contact lens wearer * clinical diagnosis of dry eye syndrome

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
Ocular exams and questionnaires at baseline and at 3 months will determine	—
the effect of cyclosporine on dry eye syndrome.	—

Secondary

Measure	Time frame
Increased contact lens wearing time due to a decrease in severity	—
of dry eye symptoms	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026